Lithium gluconate 8% in the treatment of seborrheic dermatitis;Gluconate de lithium gel à 8 p. 100 dans le traitement de la dermatite séborrhéique

Annales de Dermatologie et de Venereologie

Volumn 134, Issue 4, 2007, Pages 347-351

  Dreno B ^a   Blouin, E ^b   Moyse, D ^c  

^a NANTES UNIVERSITY HOSPITAL   (France)

^b Laboratoire Labcatal   (France)

^c NONE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

KETOCONAZOLE; LITHIODERM; LITHIUM GLUCONATE; PLACEBO; UNCLASSIFIED DRUG;

ALLERGIC RHINITIS; BURNING SENSATION; CLINICAL TRIAL; DIARRHEA; DISEASE SEVERITY; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; DRUG TOLERABILITY; ECZEMA; ERYTHEMA; HUMAN; MENTAL DISEASE; PRURITUS; REMISSION; RESPIRATORY TRACT INFECTION; REVIEW; SEBORRHEIC DERMATITIS; TREATMENT DURATION;

EID: 34248336575     PISSN: 01519638     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0151-9638(07)89189-7     Document Type: Review

References (15)

1. Chosidow O, Amblard P, Bazex J, Bernard P. Seborrheic dermatitis. Ann Dermatol Venereol 2002;129:S191-3.
2. Gupta AK, Bluhm R. Seborrheic dermatitis. J Eur Acad Dermatol Venereol 2004;18:13-26.
3. Christodoulou GN, Georgala S, Vareltzides A, Catsarou A. Lithium in seborrheic dermatitis. Psychiatr J Univ Ott 1983;8:27-9.
4. Sparsa A, Bonnetblanc JM. Lithium. Ann Dermatol Venereol 2004;131:255-61.
5. Horrobin D. Effect of lithium on essential fatty acid and prostaglandin metabolism. New-York: Springer-Verlag, 1990.
6. Bosetti F, Rintala J, Seemann R, Rosenberger TA, Contreras MA, Rapoport SI, et al. Chronic lithium downregulates cyclooxygenase-2 activity and prostaglandin E(2) concentration in rat brain. Mol Psychiatry 2002;7:845-50.
7. Weerasinghe GR, Rapoport SI, Bosetti F. The effect of chronic lithium on arachidonic acid release and metabolism in rat brain does not involve secretory phospholipase A2 or lipoxygenase/cytochrome P450 pathways. Brain Res Bull 2004;63:485-9.
8. Ballanger F, Tenaud I, Quereux G, Brocard A, Khammmari A, Dreno B. Study of the in vitro effects of lithium on normal and stimulated keratinocytes. J Invest Dermatol 2006;126:s4.
9. Horrobin DF. Lithium, fatty acid and seborrhoeic dermatitis: a new mechanism of lithium action and a new treatment for seborrhoeic dermatitis. Lithium 1990;1:149-55.
10. Smith BE, O'Day DH, Proteau GA. Lithium in the mating response and cell cycle of Saccharomyces cerevisiae. Biochem Biophys Res Commun 1995;206:401-7.
11. Dichtl B, Stevens A, Tollervey D. Lithium toxicity in yeast is due to the inhibition of RNA processing enzymes. Embo J 1997;16:7184-95.
12. Yenush L, Belles JM, Lopez-Coronado JM, Gil-Mascarell R, Serrano R, Rodriguez PL. A novel target of lithium therapy. FEBS Lett 2000;467:321-5.
13. Spiegelberg BD, Dela Cruz J, Law TH, York JD. Alteration of lithium pharmacology through manipulation of phosphoadenosine phosphate metabolism. J Biol Chem 2005;280:5400-5.
14. Dreno B, Moyse D. Lithium gluconate in the treatment of seborrhoeic dermatitis: a multicenter, randomised, double-blind study versus placebo. Eur J Dermatol 2002;12:549-52.
15. Dreno B, Chosidow O, Revuz J, Moyse D. Lithium gluconate 8% vs ketoconazole 2% in the treatment of seborrhoeic dermatitis: a multicentre, randomized study. Br J Dermatol 2003;148:1230-6.